Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/24/2025

Rh Incompatibility and Jaundice in First Babies

Understanding the Risk

  • Approximately 90% of fetomaternal hemorrhage and alloimmunization occur during delivery, meaning the first baby is typically born before significant maternal antibody production occurs, according to the American College of Emergency Physicians 1, 2.
  • Only 17% of untreated Rh-negative mothers become sensitized, even without RhIg prophylaxis after delivery of an ABO-compatible, Rh-positive infant, though actual rates may be higher as antibodies may not be detectable until a subsequent pregnancy, as reported by the American College of Emergency Physicians 1, 3.
  • Fetal RBCs displaying D-antigen appear as early as 6 weeks of gestation, and fetal cells are found in maternal circulation in 7% of first trimester pregnancies, 16% in second trimester, and 29% in third trimester, according to the American Journal of Obstetrics and Gynecology 1, 4.

Clinical Management

  • The American Academy of Pediatrics strongly recommends a direct antibody test (Coombs' test) on cord blood to detect if maternal antibodies have coated the infant's red blood cells 6, 7.
  • Monitor for jaundice systematically, assessing for jaundice at least every 8-12 hours, as jaundice progresses caudally from face to trunk and extremities, as recommended by the American Academy of Pediatrics 6, 7.
  • Obtain total serum bilirubin if jaundice is present, as visual estimation alone is unreliable, according to the American Academy of Pediatrics 6, 7.

Prevention and Treatment

  • Phototherapy is first-line treatment for hemolytic disease, initiated based on hour-specific bilirubin nomograms, as recommended by the American Academy of Pediatrics 6, 7.
  • Exchange transfusion is required for severe cases, when bilirubin approaches critical thresholds (>25 mg/dL increases kernicterus risk significantly), according to Praxis Medical Insights 8.
  • RhIg administration reduces postpartum alloimmunization from 12-13% to 1-2%, as reported by the American Journal of Obstetrics and Gynecology 4.